JPY 2020.0
(0.65%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 9.35 Billion JPY | -11.74% |
2022 | 10.6 Billion JPY | 28.15% |
2021 | 8.27 Billion JPY | -9.85% |
2020 | 9.17 Billion JPY | 27.12% |
2019 | 7.21 Billion JPY | -2.36% |
2018 | 7.39 Billion JPY | 4.45% |
2017 | 7.07 Billion JPY | 7.42% |
2016 | 6.58 Billion JPY | 7.91% |
2015 | 6.1 Billion JPY | 8.4% |
2014 | 5.63 Billion JPY | -4.38% |
2013 | 5.89 Billion JPY | -0.8% |
2012 | 5.93 Billion JPY | 7.04% |
2011 | 5.54 Billion JPY | -3.61% |
2010 | 5.75 Billion JPY | -14.46% |
2009 | 6.72 Billion JPY | 6.44% |
2008 | 6.32 Billion JPY | 8.7% |
2007 | 5.81 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 9.12 Billion JPY | -2.52% |
2023 Q2 | 10.57 Billion JPY | 3.66% |
2023 Q1 | 10.2 Billion JPY | -3.77% |
2023 Q3 | 9.64 Billion JPY | -8.82% |
2023 FY | 9.35 Billion JPY | -11.74% |
2023 Q4 | 9.35 Billion JPY | -2.96% |
2022 Q1 | 8.37 Billion JPY | 1.21% |
2022 Q3 | 8.24 Billion JPY | -6.44% |
2022 Q4 | 10.6 Billion JPY | 28.61% |
2022 FY | 10.6 Billion JPY | 28.15% |
2022 Q2 | 8.8 Billion JPY | 5.23% |
2021 Q1 | 8.36 Billion JPY | -8.82% |
2021 Q3 | 8.31 Billion JPY | -5.76% |
2021 Q4 | 8.27 Billion JPY | -0.56% |
2021 FY | 8.27 Billion JPY | -9.85% |
2021 Q2 | 8.82 Billion JPY | 5.52% |
2020 Q2 | 9.91 Billion JPY | 7.32% |
2020 FY | 9.17 Billion JPY | 27.12% |
2020 Q4 | 9.17 Billion JPY | -0.96% |
2020 Q3 | 9.26 Billion JPY | -6.58% |
2020 Q1 | 9.24 Billion JPY | 28.02% |
2019 FY | 7.21 Billion JPY | -2.36% |
2019 Q2 | 8.66 Billion JPY | 13.77% |
2019 Q4 | 7.21 Billion JPY | -6.39% |
2019 Q3 | 7.71 Billion JPY | -11.02% |
2019 Q1 | 7.61 Billion JPY | 3.03% |
2018 Q1 | 7.09 Billion JPY | 0.2% |
2018 Q2 | 7.42 Billion JPY | 4.71% |
2018 Q4 | 7.39 Billion JPY | -3.27% |
2018 FY | 7.39 Billion JPY | 4.45% |
2018 Q3 | 7.64 Billion JPY | 2.91% |
2017 Q1 | 6.96 Billion JPY | 5.76% |
2017 Q4 | 7.07 Billion JPY | 4.76% |
2017 Q3 | 6.75 Billion JPY | -5.45% |
2017 FY | 7.07 Billion JPY | 7.42% |
2017 Q2 | 7.14 Billion JPY | 2.55% |
2016 Q4 | 6.58 Billion JPY | 6.69% |
2016 FY | 6.58 Billion JPY | 7.91% |
2016 Q2 | 6.47 Billion JPY | 12.11% |
2016 Q1 | 5.77 Billion JPY | -5.44% |
2016 Q3 | 6.17 Billion JPY | -4.58% |
2015 Q1 | 5.23 Billion JPY | -7.02% |
2015 Q2 | 5.7 Billion JPY | 8.92% |
2015 Q3 | 5.46 Billion JPY | -4.17% |
2015 Q4 | 6.1 Billion JPY | 11.71% |
2015 FY | 6.1 Billion JPY | 8.4% |
2014 Q1 | 5.81 Billion JPY | -1.3% |
2014 Q2 | 6.18 Billion JPY | 6.41% |
2014 FY | 5.63 Billion JPY | -4.38% |
2014 Q4 | 5.63 Billion JPY | -5.66% |
2014 Q3 | 5.97 Billion JPY | -3.5% |
2013 Q4 | 5.89 Billion JPY | -0.87% |
2013 FY | 5.89 Billion JPY | -0.8% |
2013 Q2 | 6.1 Billion JPY | 0.46% |
2013 Q1 | 6.07 Billion JPY | 2.26% |
2013 Q3 | 5.94 Billion JPY | -2.58% |
2012 Q4 | 5.93 Billion JPY | -0.61% |
2012 FY | 5.93 Billion JPY | 7.04% |
2012 Q1 | 5.56 Billion JPY | 0.31% |
2012 Q2 | 5.88 Billion JPY | 5.7% |
2012 Q3 | 5.97 Billion JPY | 1.57% |
2011 Q3 | 5.79 Billion JPY | -2.69% |
2011 Q1 | 5.61 Billion JPY | -2.39% |
2011 Q2 | 5.95 Billion JPY | 5.93% |
2011 FY | 5.54 Billion JPY | -3.61% |
2011 Q4 | 5.54 Billion JPY | -4.21% |
2010 Q2 | 6.37 Billion JPY | 1.71% |
2010 Q3 | 5.99 Billion JPY | -6.02% |
2010 Q4 | 5.75 Billion JPY | -3.98% |
2010 FY | 5.75 Billion JPY | -14.46% |
2010 Q1 | 6.27 Billion JPY | -6.8% |
2009 Q4 | 6.72 Billion JPY | 0.65% |
2009 FY | 6.72 Billion JPY | 6.44% |
2009 Q3 | 6.68 Billion JPY | 0.0% |
2008 Q3 | 6.55 Billion JPY | -3.51% |
2008 FY | 6.32 Billion JPY | 8.7% |
2008 Q4 | 6.32 Billion JPY | -3.49% |
2008 Q2 | 6.78 Billion JPY | 0.0% |
2007 FY | 5.81 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Kitanotatsujin Corporation | 1.65 Billion JPY | -466.125% |
Euglena Co., Ltd. | 37.92 Billion JPY | 75.327% |
BEAUTY GARAGE Inc. | 6.49 Billion JPY | -44.111% |
Axas Holdings Co.,Ltd. | 14.58 Billion JPY | 35.83% |
C.I. Medical Co.,Ltd. | 21.36 Billion JPY | 56.211% |
Kao Corporation | 757.7 Billion JPY | 98.765% |
Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 90.562% |
Shiseido Company, Limited | 615.1 Billion JPY | 98.479% |
Lion Corporation | 188.22 Billion JPY | 95.029% |
Mandom Corporation | 20.05 Billion JPY | 53.349% |
Ivy Cosmetics Corporation | 1.32 Billion JPY | -605.187% |
Milbon Co., Ltd. | 7.45 Billion JPY | -25.428% |
Nippon Shikizai, Inc. | 13.56 Billion JPY | 31.001% |
Fancl Corporation | 30.56 Billion JPY | 69.392% |
KOSÉ Corporation | 88.61 Billion JPY | 89.442% |
Cota Co., Ltd. | 3.85 Billion JPY | -142.857% |
HABA Laboratories,Inc. | 3.92 Billion JPY | -138.435% |
C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -197.138% |
Pola Orbis Holdings Inc. | 33.26 Billion JPY | 71.87% |
Noevir Holdings Co., Ltd. | 24.04 Billion JPY | 61.081% |
Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -779.287% |
Almado, Inc. | 1.94 Billion JPY | -380.709% |
I-ne CO., LTD. | 8.57 Billion JPY | -9.074% |
Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | -91.73% |
Liberta Co.,Ltd. | 3.88 Billion JPY | -140.923% |
AXXZIA Inc. | 2 Billion JPY | -366.316% |
S.T. Corporation | 12.01 Billion JPY | 22.101% |
Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 85.067% |
Earth Corporation | 60.4 Billion JPY | 84.511% |
Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | -19.981% |
Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -480.046% |
Ya-Man Ltd. | 3.97 Billion JPY | -135.297% |
MTG Co., Ltd. | 11.73 Billion JPY | 20.296% |
TRANSACTION CO.,Ltd. | 4.17 Billion JPY | -124.263% |
SHOBIDO Corporation | 8.89 Billion JPY | -5.16% |
Artnature Inc. | 23.42 Billion JPY | 60.061% |
Pigeon Corporation | 19.34 Billion JPY | 51.644% |
Unicharm Corporation | 345.37 Billion JPY | 97.291% |
Paltac Corporation | 222.34 Billion JPY | 95.792% |
CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 67.187% |